AIMS: This study examined whether increasing the amount of abstinence achieved during outpatient treatment for cocaine dependence is an effective method for increasing longer-term cocaine abstinence. DESIGN: A two-condition, parallel groups, randomized controlled trial was conducted. SETTING: The trial was conducted in a university-based research clinic. PARTICIPANTS: A total of 100 cocaine-dependent outpatients participated in the trial. INTERVENTION: Participants were assigned randomly to receive treatment based on the community reinforcement approach (CRA) plus voucher-based incentives set at a relatively high monetary value (maximal value = $1995/12 weeks) or CRA with vouchers set at a relatively low monetary value (maximal value = $499/12 weeks). Vouchers were earned contingent on cocaine-negative urinalysis results during the initial 12 weeks of the 24-week outpatient treatment. MEASUREMENTS: Outcomes were evaluated using urine-toxicology testing, questionnaires and other self-report instruments. FINDINGS: Increasing voucher value increased the duration of continuous cocaine abstinence achieved during the 24-week treatment period. Point-prevalence cocaine abstinence assessed every 3 months throughout an 18-month follow-up period was greater in the high- than low-value voucher conditions. The duration of abstinence achieved during treatment predicted abstinence during follow-up, although that relationship weakened over time. CONCLUSIONS: Increasing the value of abstinence-contingent incentives during the initial weeks of treatment appears to represent an effective method for increasing during-treatment and longer-term cocaine abstinence, but the positive association of during-treatment abstinence with longer-term outcome dissipates with time.
RCT Entities:
AIMS: This study examined whether increasing the amount of abstinence achieved during outpatient treatment for cocaine dependence is an effective method for increasing longer-term cocaine abstinence. DESIGN: A two-condition, parallel groups, randomized controlled trial was conducted. SETTING: The trial was conducted in a university-based research clinic. PARTICIPANTS: A total of 100 cocaine-dependent outpatients participated in the trial. INTERVENTION: Participants were assigned randomly to receive treatment based on the community reinforcement approach (CRA) plus voucher-based incentives set at a relatively high monetary value (maximal value = $1995/12 weeks) or CRA with vouchers set at a relatively low monetary value (maximal value = $499/12 weeks). Vouchers were earned contingent on cocaine-negative urinalysis results during the initial 12 weeks of the 24-week outpatient treatment. MEASUREMENTS: Outcomes were evaluated using urine-toxicology testing, questionnaires and other self-report instruments. FINDINGS: Increasing voucher value increased the duration of continuous cocaine abstinence achieved during the 24-week treatment period. Point-prevalence cocaine abstinence assessed every 3 months throughout an 18-month follow-up period was greater in the high- than low-value voucher conditions. The duration of abstinence achieved during treatment predicted abstinence during follow-up, although that relationship weakened over time. CONCLUSIONS: Increasing the value of abstinence-contingent incentives during the initial weeks of treatment appears to represent an effective method for increasing during-treatment and longer-term cocaine abstinence, but the positive association of during-treatment abstinence with longer-term outcome dissipates with time.
Authors: Yukiko Washio; Stephen T Higgins; Sarah H Heil; Todd L McKerchar; Gary J Badger; Joan M Skelly; Robert L Dantona Journal: Exp Clin Psychopharmacol Date: 2011-06 Impact factor: 3.157
Authors: Mark K Greenwald; David M Ledgerwood; Leslie H Lundahl; Caren L Steinmiller Journal: Drug Alcohol Depend Date: 2014-03-19 Impact factor: 4.492
Authors: Donald M Dougherty; Sarah L Lake; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Jillian Mullen; John D Roache Journal: Alcohol Clin Exp Res Date: 2015-04 Impact factor: 3.455
Authors: Tara M Higgins; Stephen T Higgins; Sarah H Heil; Gary J Badger; Joan M Skelly; Ira M Bernstein; Laura J Solomon; Yukiko Washio; Adrien M Preston Journal: Nicotine Tob Res Date: 2010-03-25 Impact factor: 4.244
Authors: Randall E Rogers; Stephen T Higgins; Kenneth Silverman; Colleen S Thomas; Gary J Badger; George Bigelow; Maxine Stitzer Journal: Psychol Addict Behav Date: 2008-12
Authors: Michael J Mancino; Janette McGaugh; Mohit P Chopra; Joseph B Guise; Christopher Cargile; D Keith Williams; Jeff Thostenson; Thomas R Kosten; Nichole Sanders; Alison Oliveto Journal: J Clin Psychopharmacol Date: 2014-04 Impact factor: 3.153